$3.17
0.206.73%
At close: May 26, 5:00 PM EST
$3.09
0.124.04%
Pre-Market: 8:07 AM EST
Recursion Pharmaceuticals Inc Earnings Estimates
RXRXNASDAQ
Recursion Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:RXRX
Recursion Pharmaceuticals (RXRX) is scheduled to report Q2 earnings on August 4, 2026. Analysts estimate EPS of $-0.24 and quarterly revenue of $13.50M.
In the most recent quarter (Q1), Recursion Pharmaceuticals reported EPS of $-0.22, beating estimates of $-0.27 by 0.19%. Revenue came in at $6.47M, missing the estimate of $15.86M by 0.59%.
Recursion Pharmaceuticals has beaten EPS estimates in 3 consecutive quarters.
Over the last 4 quarters, Recursion Pharmaceuticals has averaged an EPS surprise of 0.18% and a revenue surprise of 0.51%.
Earnings Date
Aug 4
EPS Estimate
$-0.240
Quarterly Revenue Estimate
$13.50M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$65.74M
Recursion Pharmaceuticals Earnings History
Analyze the earnings history of Recursion Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Recursion Pharmaceuticals (RXRX) Earnings Per Share
The chart below shows Recursion Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Recursion Pharmaceuticals (RXRX) Revenue
The chart below shows Recursion Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Recursion Pharmaceuticals (NASDAQ:RXRX) reporting earnings?
Recursion Pharmaceuticals (RXRX) is scheduled to report earnings on August 4, 2026. The last reported earnings were for reported on May 6, 2026 for Q1.
What were the latest earnings per share (EPS) for Recursion Pharmaceuticals (NASDAQ:RXRX)?
The Actual EPS was $-0.22, which beat the estimate of $-0.27.
What were Recursion Pharmaceuticals’s (NASDAQ:RXRX) revenues?
The Actual Revenue was $6.47M, which missed the estimate of $15.86M.
